514 related articles for article (PubMed ID: 28110063)
1. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation.
Afrin R; Arumugam S; Rahman A; Wahed MI; Karuppagounder V; Harima M; Suzuki H; Miyashita S; Suzuki K; Yoneyama H; Ueno K; Watanabe K
Int Immunopharmacol; 2017 Mar; 44():174-182. PubMed ID: 28110063
[TBL] [Abstract][Full Text] [Related]
2. Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling.
Afrin MR; Arumugam S; Rahman MA; Karuppagounder V; Harima M; Suzuki H; Miyashita S; Suzuki K; Ueno K; Yoneyama H; Watanabe K
Int Immunopharmacol; 2017 Aug; 49():161-167. PubMed ID: 28595079
[TBL] [Abstract][Full Text] [Related]
3. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice.
Luo Y; Dong X; Yu Y; Sun G; Sun X
J Ethnopharmacol; 2015 Apr; 163():241-50. PubMed ID: 25655997
[TBL] [Abstract][Full Text] [Related]
4. [Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice].
Chen XM; Li FQ; Yan S; Wu XC; Tang CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):777-782. PubMed ID: 27752155
[TBL] [Abstract][Full Text] [Related]
5. Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet.
Okada H; Takabatake R; Honda M; Takegoshi K; Yamashita T; Nakamura M; Shirasaki T; Sakai Y; Shimakami T; Nagata N; Takamura T; Tanaka T; Kaneko S
Oncotarget; 2017 Jun; 8(25):39978-39993. PubMed ID: 28591717
[TBL] [Abstract][Full Text] [Related]
6. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
[TBL] [Abstract][Full Text] [Related]
7. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
[TBL] [Abstract][Full Text] [Related]
9. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
10. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
11. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of
Lee DE; Lee SJ; Kim SJ; Lee HS; Kwon OS
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717261
[TBL] [Abstract][Full Text] [Related]
13. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway.
Chtourou Y; Fetoui H; Jemai R; Ben Slima A; Makni M; Gdoura R
Eur J Pharmacol; 2015 Jan; 746():96-105. PubMed ID: 25446569
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non-alcoholic steatohepatitis model.
Shimizu Y; Tamura T; Kemmochi A; Owada Y; Ozawa Y; Hisakura K; Matsuzaka T; Shimano H; Nakano N; Sakashita S; Oda T; Ohkohchi N
J Gastroenterol Hepatol; 2021 Mar; 36(3):800-810. PubMed ID: 32870526
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model.
Aoyama Y; Naiki-Ito A; Xiaochen K; Komura M; Kato H; Nagayasu Y; Inaguma S; Tsuda H; Tomita M; Matsuo Y; Takiguchi S; Takahashi S
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010924
[TBL] [Abstract][Full Text] [Related]
16. Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2/4-NF-κB signaling pathways.
Li X; Jin Q; Yao Q; Xu B; Li Z; Tu C
Toxicol Lett; 2016 Nov; 261():1-12. PubMed ID: 27601294
[TBL] [Abstract][Full Text] [Related]
17. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
Tucker RD; Ciofoaia V; Nadella S; Gay MD; Cao H; Huber M; Safronenka A; Shivapurkar N; Kallakury B; Kruger AJ; Kroemer AHK; Smith JP
Dig Dis Sci; 2020 Jan; 65(1):189-203. PubMed ID: 31297627
[TBL] [Abstract][Full Text] [Related]
18. Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice.
Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
Int Immunopharmacol; 2019 Oct; 75():105797. PubMed ID: 31421545
[TBL] [Abstract][Full Text] [Related]
19. Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF-κB signaling and reducing oxidative stress.
Lee GR; Lee HI; Kim N; Lee J; Kwon M; Kang YH; Song HJ; Yeo CY; Jeong W
J Cell Physiol; 2022 Sep; 237(9):3554-3564. PubMed ID: 35696549
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Investigation of Ceraceomyces tessulatus (Agaricomycetes) in Mice with Nonalcoholic Steatohepatitis.
Watanabe K; Afrin R; Sreedhar R; Karuppagounder V; Harima M; Alexander X; Velayutham R; Arumugam S
Int J Med Mushrooms; 2020; 22(7):683-692. PubMed ID: 32865925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]